Amedeo's Top 20

Amedeo Smart

Independent Medical Education

21 August 2017

Multidisciplinary Journal Club

  1. Jackson ML, Chung JR, Jackson LA, Phillips CH, et al.
    Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.
    N Engl J Med 2017;377:534-543.

  1. Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, et al.
    Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Lancet 2017.

  2. Kattakuzhy S, Gross C, Emmanuel B, Teferi G, et al.
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med 2017.

  3. Frank JW, Lovejoy TI, Becker WC, Morasco BJ, et al.
    Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review.
    Ann Intern Med 2017;167:181-191.

  4. Jorgensen KK, Olsen IC, Goll GL, Lorentzen M, et al.
    Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
    Lancet 2017.

  1. Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al.
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology 2017;152:1544-1577.

  2. Burns RB, Smetana GW, Brady R.
    Should This Patient Receive an Antidepressant?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med 2017;167:192-199.

  3. Coles CE, Griffin CL, Kirby AM, Titley J, et al.
    Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Lancet 2017.

  4. Lau DH, Nattel S, Kalman JM, Sanders P, et al.
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation 2017;136:583-596.

  5. Hallek M.
    Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
    Am J Hematol 2017;92:946-965.

  1. Patorno E, Glynn RJ, Levin R, Lee MP, et al.
    Benzodiazepines and risk of all cause mortality in adults: cohort study.
    BMJ 2017;358:j2941.

  2. Jansen PL, Ghallab A, Vartak N, Reif R, et al.
    The ascending pathophysiology of cholestatic liver disease.
    Hepatology 2016.

  3. Reber LL, Hernandez JD, Galli SJ.
    The pathophysiology of anaphylaxis.
    J Allergy Clin Immunol 2017;140:335-348.

  4. Lofgren J, Mortensen J, Rasmussen SH, Madsen C, et al.
    A prospective study comparing 99mTc-HDP planar bone scintigraphy and whole-body SPECT/CT with 18F-fluoride PET/CT and 18F-fluoride PET/MRI for diagnosing bone metastases.
    J Nucl Med 2017.

  5. Xie W, Regan MM, Buyse M, Halabi S, et al.
    Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.
    J Clin Oncol 2017.

  1. Richter JE, Rubenstein JH.
    Presentation and Epidemiology of Gastroesophageal Reflux Disease.
    Gastroenterology 2017.

  2. Johansson H, Azizieh F, Al Ali N, Alessa T, et al.
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int 2017.

  3. Kelly JM, Rubenfeld GD, Masson N, Min A, et al.
    Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm.
    Crit Care Med 2017;45:e607-e616.

  4. Cadier B, Bulsei J, Nahon P, Seror O, et al.
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology 2017.

  5. Healey JS, Alings M, Ha AC, Leong-Sit P, et al.
    Subclinical Atrial Fibrillation in Older Patients.
    Circulation 2017.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016